Hogan Lovells Our thinking banner

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Insights and Analysis

FDA endorses prior knowledge use in gene therapy development

09 June 2026

News

Drug repurposing: FDA seeks comments on how to address unmet medical needs

26 May 2026

News

Reminder: Key Extended Producer Responsibility (EPR) Reporting Deadlines Approaching

21 May 2026

Insights and Analysis

Trump Administration seeks information to relaunch nuclear-powered commercial shipping

13 May 2026

News

Permanent Regulations for California’s Extended Producer Responsibility Law (SB 54) Take Effect

08 May 2026

News

House committee report signals limits on foreign clinical data

06 May 2026

Insights and Analysis

Practical considerations for using AI in analyzing clinical data and preparing FDA submissions

30 April 2026

News

Medical devices incorporating AI – Navigating roles and responsibilities of manufacturers/providers and users/deployers under the MDR and AIA

30 April 2026

Insights and Analysis

Trump promotes psychedelic drug availability but legal issues remain

24 April 2026

News

U.S. Department of Education publishes initial draft regulations and starts AIM Committee meetings

23 April 2026

News

Department of War updates its research security decision matrix

22 April 2026

News

New Blanche memo confirms shift in fraud crackdown: What the new National Fraud Enforcement Division means for business

09 April 2026

Load more

Digital Client Solutions

Empowering you to lead change through our digital solutions.